NCT07237061

Brief Summary

This study looks at whether aromatherapy (scent chosen by the patient), is better than routine care, at reducing preoperative anxiety before eye surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
Last Updated

November 19, 2025

Status Verified

June 1, 2025

Enrollment Period

1.1 years

First QC Date

June 26, 2025

Last Update Submit

November 17, 2025

Conditions

Keywords

randomized controlled trialplacebo controlleddouble blindedtwo arm

Outcome Measures

Primary Outcomes (1)

  • change in VAS scores for preoperative anxiety

    preoperative anxiety was ranked by the patient on a scale of 0-100 on a visual acuity scale (VAS) measuring 100mm, in the preoperative ambulatory ward, before and after the intervention/placebo was applied for at least 30 minutes. The change in the VAS score at these 2 timepoints was the primary outcome

    30-60 minutes

Study Arms (2)

placebo

PLACEBO COMPARATOR

Patients were asked to choose amongst 4 different aromatherapy scents. The study administrator then stuck an adhesive patch without any aromatherapy oil on it, to the patient's facemask. This was worn throughout the perioperative experience from the ambulatory ward to the operating theatre and post anaesthesia care unit (PACU).

Other: Placebo

intervention

EXPERIMENTAL

Patients were asked to choose amongst 4 different aromatherapy scents. The study administrator then stuck an adhesive patch with 1 drop of their chosen aromatherapy oil on it, to the patient's facemask. This was worn throughout the perioperative experience from the ambulatory ward to the operating theatre and post anaesthesia care unit (PACU).

Other: Aromatherapy

Interventions

patients chose their preferred aromatherapy scent to be used for at least 30 minutes

Also known as: lavender, geranium, lemongrass, sandalwood
intervention
PlaceboOTHER

odorless dry absorbent adhesive patch

placebo

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • mental capacity for informed consent
  • undergoing elective ambulatory eye surgery (including Phacoemulsification, Femtosecond laser-assisted cataract surgery (FLACS), Extracapsular cataract extraction (ECCE) and vitrectomy).
  • surgery only under Monitored Anaesthesia Care (MAC)3
  • surgical duration less than 45 minutes

You may not qualify if:

  • anosmia
  • allergy to aromatherapy oil
  • asthma
  • allergic rhinitis
  • psychiatric disease
  • altered mental state
  • lack of mental capacity
  • active infection
  • pregnancy
  • patient or surgeon refused participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital Singapore

Singapore, Singapore

Location

MeSH Terms

Conditions

Cataract

Interventions

Aromatherapylavender oillemongrass oil

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPhytotherapySensory Art TherapiesPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2025

First Posted

November 19, 2025

Study Start

March 1, 2023

Primary Completion

March 31, 2024

Study Completion

December 1, 2024

Last Updated

November 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

local Patient Data Protection Act

Locations